Abnormal cardiac adrenergic neuron activity assessed by I-123-MIBG is an early marker of cardiac dysfunction in doxorubicin-induced cardiomyopathy in rats

Bertrand Collin (1, 2) , A. Oudot (3) , J.M. Vrigneaud (3) , S. Delemasure (4) , M. Guillemin (3) , Paul Walker (5, 6) , Alain Lalande (6, 5) , Alexandre Cochet (6, 1) , François Brunotte (6, 1)

1 UNICANCER/CRLCC-CGFL - Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon]
2 ICMUB - Institut de Chimie Moléculaire de l'Université de Bourgogne [Dijon]
3 CGFL - Plateforme d'imagerie préclinique [Centre Georges-François Leclerc]
4 Cohiro Biotechnology
5 CHU Dijon
6 Le2i - Laboratoire Electronique, Informatique et Image [UMR6306]

Domaines: Ingénierie biomédicale

Bertrand Collin, A. Oudot, J.M. Vrigneaud, S. Delemasure, M. Guillemin, et al.. Abnormal cardiac adrenergic neuron activity assessed by I-123-MIBG is an early marker of cardiac dysfunction in doxorubicin-induced cardiomyopathy in rats. Annual Congress of the European Association of Nuclear Medicine, Oct 2016, Barcelone, Spain. pp.S88-S89 / OP287, ⟨10.1007/s00259-016-3484-4⟩. ⟨hal-01477976⟩